IP Library Granted Patent US 11,864,813
Granted Patent B2
US 11,864,813 · App. 16/874,042 · Granted Jan 9, 2024

Evaluation of consumed energy in electrosurgical systems

Inventors: Kester Julian Batchelor (Mound, MN); Riyad Moe (Madison, WI); Wayne Williams (Penarth, GB)
Assignee: Gyrus ACMI, Inc.
A61B18/1206A61B18/00A61B18/1233A61B18/14A61B18/1442A61B18/1445A61B2017/00017A61B2017/00115A61B2017/00132A61B2017/00154A61B2017/00194A61B2018/0063A61B2018/0072A61B2018/0075A61B2018/00589A61B2018/00595A61B2018/00642A61B2018/00648A61B2018/00654A61B2018/00666A61B2018/00678A61B2018/00684A61B2018/00702A61B2018/00708A61B2018/00714A61B2018/00755A61B2018/00761A61B2018/00767A61B2018/00779A61B2018/00791A61B2018/00827A61B2018/00875A61B2018/00886A61B2018/00898A61B2018/00928A61B2018/00994A61B2018/1455A61B2018/1467
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,864,813
App. No.
16/874,042
Granted
Jan 9, 2024
Kind
B2
Abstract

Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.

Claims (58)

1. A surgical generator configured to generate and provide a therapeutic signal to biological tissue in electrical communication with a surgical instrument, the surgical generator comprising:

a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to:

control an energy delivery of the therapeutic signal provided to the biological tissue during at least one of an interrogation phase and a first drying phase, the interrogation phase being to obtain electrical properties of the biological tissue, and the first drying phase being to dry or desiccate the biological tissue;

after completion of at least the first drying phase, compare an amount of energy delivered to the biological tissue during the at least one of the interrogation phase and the first drying phase to a threshold energy value; and

adjust the delivery of the therapeutic signal based on the comparison and continue delivery of the therapeutic signal,

wherein the control circuit configured to adjust delivery of the therapeutic signal based on the comparison is further configured to:

control delivery of the energy of the therapeutic signal provided to the biological tissue in order to perform a second drying phase if the amount of energy delivered exceeds the threshold energy value during the at least one of the interrogation phase and the first drying phase,

wherein a power ramp rate for the second drying phase is less than a power ramp rate for the first drying phase.

2. The surgical generator of claim 1 , wherein the control circuit is configured to:

control an electrical power of the therapeutic signal provided to the biological tissue.

3. The surgical generator of claim 1 , wherein the control circuit is configured to:

control a voltage of the therapeutic signal provided to the biological tissue.

4. The surgical generator of claim 1 , wherein the control circuit configured to continue delivery of the therapeutic signal based on the comparison is configured to:

control the energy delivery of the therapeutic signal provided to the biological tissue in order to perform a finishing phase to coagulate the biological tissue if the amount of energy delivered is less than the threshold energy value during the at least one of the interrogation phase and the first drying phase.

5. The surgical generator of claim 1 , comprising:

a measurement circuit coupled to the control circuit and configured to measure an impedance of the biological tissue;

wherein the control circuit is configured to:

determine a power ramp rate for delivery of the therapeutic signal based on the measured impedance.

6. The surgical generator of claim 5 , wherein the control circuit is configured to:

determine a difference between first and second measured impedances; and

adjust the power ramp rate in response to the determined difference being less than a predetermined delta impedance value.

7. The surgical generator of claim 6 , wherein the control circuit configured to adjust the power ramp rate in response to the determined difference being less than the predetermined delta impedance value is configured to:

increase the power ramp rate until either the determined difference is equal to or greater than the predetermined delta impedance value or the amount of energy delivered is equal to or greater than the threshold energy value.

8. The surgical generator of claim 1 , comprising:

a measurement circuit coupled to the control circuit and configured to measure an impedance of the biological tissue;

wherein the control circuit is configured to:

during a finishing phase to coagulate the biological tissue:

initiate a timer;

determine a difference between measured impedances and compare the determined difference to a predetermined delta impedance value; and

in response to the determined difference being equal to or greater than the predetermined delta impedance value and the timer being greater than a threshold time limit, generate an error signal.

9. The surgical generator of claim 8 , wherein the error signal is an open circuit error signal.

10. The surgical generator of claim 1 , wherein the control circuit configured to continue delivery of the therapeutic signal based on the comparison is configured to:

repeat a drying phase to dry or desiccate the biological tissue.

11. A surgical generator configured to generate and provide a therapeutic signal to biological tissue in electrical communication with a surgical instrument, the surgical generator comprising:

a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to:

control an energy delivery of the therapeutic signal provided to the biological tissue during at least one of an interrogation phase and a first drying phase, the interrogation phase being to obtain electrical properties of the biological tissue, and the first drying phase being to dry or desiccate the biological tissue;

after completion of at least the first drying phase, compare an amount of charge delivered to the biological tissue during the at least one of the interrogation phase and the first drying phase to a charge threshold value; and

adjust the delivery of the therapeutic signal based on the comparison and continue delivery of the therapeutic signal,

wherein the control circuit configured to adjust delivery of the therapeutic signal based on the comparison is further configured to:

control delivery of the energy of the therapeutic signal provided to the biological tissue in order to perform a second drying phase if the amount of charge delivered exceeds the charge threshold value during the at least one of the interrogation phase and the first drying phase,

wherein a power ramp rate for the second drying phase is less than a power ramp rate for the first drying phase.

12. The surgical generator of claim 11 , wherein the control circuit configured to continue delivery of the therapeutic signal based on the comparison is configured to:

control the energy delivery of the therapeutic signal provided to the biological tissue in order to perform a finishing phase to coagulate the biological tissue if the amount of charge delivered is less than the charge threshold value during the at least one of the interrogation phase and the first drying phase.

13. A method of operating a surgical generator configured to generate and provide a therapeutic signal to biological tissue in electrical communication with a surgical instrument, wherein the surgical generator includes a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the method comprising:

controlling an energy delivery of the therapeutic signal provided to the biological tissue during at least one of an interrogation phase and a first drying phase, the interrogation phase being to obtain electrical properties of the biological tissue, and the first drying phase being to dry or desiccate the biological tissue;

after completion of at least the first drying phase, comparing an amount of energy delivered to the biological tissue during the at least one of the interrogation phase and the first drying phase to a threshold energy value; and

adjusting the delivery of the therapeutic signal based on the comparison and continuing delivery of the therapeutic signal, including:

controlling delivery of the energy of the therapeutic signal provided to the biological tissue in order to perform a second drying phase if the amount of energy delivered exceeds the threshold energy value during the at least one of the interrogation phase and the first drying phase,

wherein a power ramp rate for the second drying phase is less than a power ramp rate for the first drying phase.

14. The method of claim 13 , comprising:

controlling an electrical power of the therapeutic signal provided to the biological tissue.

15. The method of claim 13 , comprising:

controlling a voltage of the therapeutic signal provided to the biological tissue.

16. The method of claim 13 , wherein continuing delivery of the therapeutic signal based on the comparison includes:

controlling the energy delivery of the therapeutic signal provided to the biological tissue during a finishing phase if the amount of energy delivered is less than the threshold energy value.

17. The method of claim 13 , comprising:

measuring an impedance of the biological tissue; and

determining a power ramp rate for delivery of the therapeutic signal based on the measured impedance.

Assignments (4)
CONFIRMATORY ASSIGNMENT Recorded Nov 18, 2022
From: GYRUS MEDICAL LIMITED
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 061966/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2022
From: WILLIAMS, WAYNE
To: GYRUS MEDICAL LIMITED
Reel/Frame 058756/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2022
From: BATCHELOR, KESTER JULIAN
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 058711/0935 →
EMPLOYMENT AGREEMENT Recorded Jan 20, 2022
From: MOE, RIYAD
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 058786/0581 →
Continuity (8)
Continuation PCTUS2020031857 · May 7, 2020
Provisional Application 62845647 · May 9, 2019
Provisional Application 62905318 · Sep 24, 2019
Provisional Application 62905366 · Sep 24, 2019
Provisional Application 62905337 · Sep 24, 2019
Provisional Application 62905345 · Sep 24, 2019
Provisional Application 62905360 · Sep 24, 2019
Related Publication 20200352624A1 · Nov 12, 2020
Cited By (4)
US 12,193,721 US 12,303,183 US 12,440,262 US 12,714,489